Impact of cryopreservation and freeze-thawing on therapeutic properties of mesenchymal stromal/stem cells and other common cellular therapeutics
C Cottle, AP Porter, A Lipat, C Turner-Lyles… - Current stem cell …, 2022 - Springer
Abstract Purpose of Review Cryopreservation and its associated freezing and thawing
procedures–short “freeze-thawing”–are among the final steps in economically viable …
procedures–short “freeze-thawing”–are among the final steps in economically viable …
Allogeneic hematopoietic stem cell transplantation in the COVID-19 era
J Bordat, S Maury, M Leclerc - Frontiers in immunology, 2023 - frontiersin.org
Allogeneic hematopoietic stem-cell transplantation (allo-HSCT) recipients are especially
vulnerable to coronavirus disease 19 (COVID-19), because of their profound …
vulnerable to coronavirus disease 19 (COVID-19), because of their profound …
Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT …
N Worel, P Ljungman, ICM Verheggen… - Bone Marrow …, 2023 - nature.com
The COVID-19 pandemic has had a significant impact on medical practices, including the
delivery of allogeneic hematopoietic cell transplantation (HCT). In response, transplant …
delivery of allogeneic hematopoietic cell transplantation (HCT). In response, transplant …
Suitability of haematopoietic cell donors: updated consensus recommendations from the WBMT standing committee on donor issues
N Worel, M Aljurf, C Anthias, AS Buser… - The Lancet …, 2022 - thelancet.com
The contribution of related donors to the globally rising number of allogeneic haematopoietic
stem cell transplantations (HSCT) remains increasingly important, particularly because of …
stem cell transplantations (HSCT) remains increasingly important, particularly because of …
[HTML][HTML] Lower incidence of chronic GVHD observed after transplantation with cryopreserved unrelated allogeneic stem cells
K Maurer, HT Kim, HM Garrity, D Liney, C Cutler… - Blood …, 2023 - ncbi.nlm.nih.gov
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) typically utilizes fresh donor
bone marrow (BM) or peripheral blood stem cells (PBSCs) because of concerns that …
bone marrow (BM) or peripheral blood stem cells (PBSCs) because of concerns that …
Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemic
SM Devine, S Bo-Subait, M Kuxhausen… - Blood …, 2023 - ashpublications.org
At the onset of the COVID-19 pandemic, the National Marrow Donor Program mandated the
cryopreservation of hematopoietic cell grafts from volunteer unrelated donors because of …
cryopreservation of hematopoietic cell grafts from volunteer unrelated donors because of …
Real-world experience of cryopreserved allogeneic hematopoietic grafts during the COVID-19 pandemic: a single-center report
AK Bankova, J Caveney, B Yao, TL Ramos… - … and Cellular Therapy, 2022 - Elsevier
In response to the widespread COVID-19 pandemic, cryopreservation of allogeneic donor
apheresis products was implemented to mitigate the challenges of donor availability and …
apheresis products was implemented to mitigate the challenges of donor availability and …
Impact of cryopreservation of peripheral blood stem cells (PBSC) in transplantation from matched unrelated donor (MUD)
G Facchin, C Savignano, ML Battista, M Isola… - Journal of Clinical …, 2022 - mdpi.com
Background: Cryopreservation of PBSC for allogenic hematopoietic stem cell transplantation
(allo-HSCT) was implemented due to the current Coronavirus 2019 pandemic. The impact of …
(allo-HSCT) was implemented due to the current Coronavirus 2019 pandemic. The impact of …
Leukocytapheresis variables and transit time for allogeneic cryopreserved hpc: better safe than sorry
J Fernandez-Sojo, R Horton, J Cid, C Azqueta… - Bone Marrow …, 2022 - nature.com
Cryopreservation was recommended to ensure continuity in allogeneic hematopoietic
progenitor cells (HPC) transplantation during the COVID-19 pandemic. Several groups have …
progenitor cells (HPC) transplantation during the COVID-19 pandemic. Several groups have …
Coordinated immune cell networks in the bone marrow microenvironment define the graft versus leukemia response with adoptive cellular therapy
Donor lymphocyte infusion (DLI) is an established therapy for relapsed acute myeloid
leukemia (AML) after hematopoietic stem cell transplant (HSCT), but response rates are …
leukemia (AML) after hematopoietic stem cell transplant (HSCT), but response rates are …